Unknown PHASE4 INTERVENTIONAL 1-arm NCT01190371

Have Malaria Infections in Kenya Become Less Responsive to Artemisinin Treatment? (CATMAP)

Confirmation of Artemisinin Tolerance in Malaria Parasites Trial in Kilifi

Sponsor: Heidelberg University

Conditions Malaria

Interventions Artesunate

Updated 6 times since 2017 Last updated: Feb 22, 2018 Started: Apr 30, 2011 Primary completion: Nov 30, 2011 Completion: Dec 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Malaria, this trial is ongoing. The trial is conducted by Heidelberg University and has accumulated 6 data snapshots since 2011. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Aug 2019 — Jan 2021 [monthly]

Unknown Status PHASE4

Status: Active Not Recruiting → Unknown Status
Jun 2018 — Aug 2019 [monthly]

Active Not Recruiting PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Active Not Recruiting PHASE4

First recorded

Apr 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Heidelberg University
KEMRI-Wellcome Trust Collaborative Research Program
University of Oxford

Data source: KEMRI-Wellcome Trust Collaborative Research Program

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kadzinuni, Kenya
• Kilifi, Kenya